Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

Pharmacological evaluation of dotinurad, a selective urate reabsorption inhibitor

(2019) Tetsuya Taniguchi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study

(2017) Anne-Kathrin Tausche et al.   RHEUMATOLOGY

Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension

(2014) Masanari Kuwabara et al.   HYPERTENSION RESEARCH

Hyperuricemia Is a Significant Risk Factor for the Onset of Chronic Kidney Disease

(2014) Akiko Toda et al.   NEPHRON CLINICAL PRACTICE

High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies

(2013) Qin Lv et al.   PLoS One

Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition

(2011) Hisashi Yamanaka   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Febuxostat: a new treatment for hyperuricaemia in gout

(2009) N. L. Edwards   RHEUMATOLOGY